Stocks and Investing
Stocks and Investing
Thu, June 23, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, June 22, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mark Massaro Initiated (AKYA) at Strong Buy and Held Target at $16 on, Jun 22nd, 2022
Mark Massaro of BTIG, Initiated "Akoya Biosciences, Inc." (AKYA) at Strong Buy and Held Target at $16 on, Jun 22nd, 2022.
Mark has made no other calls on AKYA in the last 4 months.
There are 2 other peers that have a rating on AKYA. Out of the 2 peers that are also analyzing AKYA, 0 agree with Mark's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mark
- David Westenberg of "Piper Sandler" Maintained at Buy with Decreased Target to $14 on, Monday, May 16th, 2022
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $18 on, Monday, May 9th, 2022
Contributing Sources